CONGRESS|#EHA2021|Fredrik Schjesvold, presented about new trials & combinations of monoclonal antibodies in MM. Benefits and increasing efficacy in all lines of treatment was discussed #mmsm, #myeloma Oslo University hospital pic.twitter.com/N4x6HtO9vQ
— Multiple Myeloma Hub (@MM_Hub) June 12, 2021